NASDAQ:MYMD - Nasdaq - US62856X2018 - Common Stock - Currency: USD
TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 16.02M | 15.28M | 28.80M | 12.29M | 3.39M | |||
Research and Development | 7.37M | 9.07M | 6.75M | 7.96M | 0.00 | |||
Selling, General, and Administrative Expenses | 7.89M | 6.22M | 21.46M | 4.32M | 3.40M | |||
Operating Income | -16.02M | -15.28M | -28.80M | -12.29M | -3.39M | |||
Interest Income/Expense | 1.35M | 80.00K | 10.00K | 140.00K | 100.00K | |||
Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
Non Recurring Items | -180.00K | 0.00 | -1.09M | 0.00 | -80.00K | |||
Income Before Taxes | -5.39M | -15.20M | -29.89M | -12.15M | -3.38M | |||
Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Net Income | -7.08M | -15.20M | -29.89M | -17.58M | -3.89M | |||
EBITDA | N/A | N/A | N/A | -12.26M | -3.32M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.18 | -0.39 | -0.85 | -4.98 | -12.54 | |||
Statistics | ||||||||
Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
Operating Profit Margin | N/A | N/A | N/A | N/A | N/A |
All data in USD